
Thermo Fisher Scientific Inc. owns 4 brands in our database. Browse the complete portfolio of Thermo Fisher Scientific Inc. subsidiaries and brands across various industries.
Company Type
public
Headquarters
Waltham, Massachusetts, USA
Brand Portfolio
4 brands
Stock
NYSE: TMO
Healthcare PharmaceuticalsOwned by Thermo Fisher Scientific Inc.
Genetic analysis instruments and reagents brand of Thermo Fisher Scientific Inc. (NYSE: TMO), known for PCR and DNA sequencing systems used in research and forensics.
Healthcare PharmaceuticalsOwned by Thermo Fisher Scientific Inc.
Laboratory supply distribution brand of Thermo Fisher Scientific Inc. (NYSE: TMO), founded in 1902 in Pittsburgh and now one of the largest lab supply channels in the world.
Healthcare PharmaceuticalsOwned by Thermo Fisher Scientific Inc.
Life sciences reagents and cell biology products brand of Thermo Fisher Scientific Inc. (NYSE: TMO), founded in 1987 and covering cloning, antibodies, and cell culture.
Healthcare PharmaceuticalsOwned by Thermo Fisher Scientific Inc.
Laboratory instruments, equipment, software, and consumables brand of Thermo Fisher Scientific Inc. (NYSE: TMO), covering mass spectrometry, microscopy, and lab products.
Who owns Thermo Fisher Scientific?
Thermo Fisher Scientific is an independent publicly traded company listed on the NYSE under TMO. No single shareholder controls it; ownership is spread across institutional investors and the public.
When was Thermo Fisher formed?
Thermo Fisher Scientific was created in 2006 by the merger of Thermo Electron, founded in 1956, and Fisher Scientific, founded in 1902.
What brands does Thermo Fisher own?
Its major brands are Thermo Scientific, Fisher Scientific, Applied Biosystems, Invitrogen, Unity Lab Services, Patheon, and PPD.
Who is the CEO of Thermo Fisher?
Marc Casper has been chairman, president, and CEO since 2009. He joined Thermo Electron in 2001 and led the company through the 2006 merger.
What was Thermo Fisher's revenue in 2025?
Revenue was $44.56 billion in fiscal 2025, up 4% from $42.88 billion in 2024. GAAP diluted EPS was $17.74.
What does PPD do?
PPD is Thermo Fisher's contract research organization, acquired in 2021 for $17.4 billion. It manages clinical trials and development programs for pharmaceutical and biotech clients.
No competing brands found in the same categories. This could be because Thermo Fisher Scientific Inc.operates in unique market segments or we're still building our competitor database.
Thermo Fisher Scientific Inc. maintains a diverse portfolio of 4 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Thermo Fisher Scientific Inc.provides valuable insights into market dynamics, product relationships, and corporate strategy.